m-RNA 合成服务市场：按应用、运营规模、最终用户（生物製药公司、CRO、其他）、地区 - 规模、份额、前景、机会分析，2023-2030 年

转录是以 DNA 为模板合成信使 RNA (mRNA)。 mRNA 将遗传信息从细胞核中的染色体 DNA 携带到细胞质表面。 mRNA 是用于基因编辑、细胞治疗、疫苗接种和治疗性蛋白质替代的灵活工具。 由于可以通过 mRNA 引入任何蛋白质，因此可以在细胞内产生基因编辑工具和抗原。

mRNA 是一种单链 RNA 分子，与基因的一条 DNA 链互补。 合成 mRNA 用于研究蛋白质介导的 mRNA 识别、mRNA 输出和翻译、突变对蛋白质编码基因的影响等。 近年来，开发了使用mRNA的药物用于治疗各种疾病，例如呼吸系统疾病、心脏病、代谢疾病、自身免疫性疾病、癌症、癌症免疫疗法和疫苗接种。

市场动态

预计市场参与者之间收购的增加将推动预测期内的市场增长。 例如，2022 年 1 月，为研究人员和生物技术创新者提供生命科学试剂和服务的全球供应商 Maravai LifeSciences, Inc. 以 2.4 亿美元的价格收购了专注于製造超纯核甘酸的公司 Mychem, LLC。以 100 万美元的价格收购了该公司。 此次收购扩大了 Maravai 的产品组合，为快速增长的 mRNA 治疗和疫苗应用市场提供战略投入。

市场参与者增加对基于 m-RNA 的 m-RNA 合成技术的投资以扩大其产品组合，预计将在预测期内推动市场增长。. 例如，2021年12月，金融公司Direxion宣布推出Direxion mRNA ETF，这是一隻专注于信使RNA技术应用和开发的新型交易所交易基金（ETF）。 该基金的目的是投资于正在开发和应用 mRNA 技术的公司。

这项研究的主要特点

• 本报告详细分析了全球 m-RNA 合成服务市场，提出了以 2022 年为基准年的预测期 (2023-2030) 的市场规模（美国）和復合年增长率 (CAGR%)。）发布。
• 它阐明了各个细分市场的潜在收入机会，并概述了该市场具有吸引力的投资建议矩阵。
• 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，对全球 m-RNA 合成服务市场的主要参与者进行介绍。 本研究涵盖的主要公司包括 Maravai LifeSciences、Azenta US, Inc.、Creative Biolabs、Becton、Dickinson And Company、Creative Biogene、Kaneka Corporation、Danaher、eTheRNA、Biomay AG、ApexBio Technology、RiboPro、F. Hoffmann -La Roche Ltd 、System Biosciences, LLC.、Aurigene Pharmaceutical Services Ltd.、OZ Biosciences、Aldevron 和 GenScript 包含
• 。
• 这份报告中的见解将使企业营销人员和高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 《全球 m-RNA 合成服务市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球 m-RNA 合成服务市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写

第二章市场概况

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按应用分类
  • 市场概况：按操作规模
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场吸引力分析
  • 市场机会
  • 产品发布
  • 合併/收购/联合研究
  • 监管准则和合规性
  • 主要发展
  • 害虫分析
  • 技术概况
  • 服务成本分析

第 4 章 m-RNA 合成服务的全球市场 - 冠状病毒 (COVID-19) 大流行的影响

• 对经济的影响
• COVID-19 流行病学
• 对供需的影响

第 5 章 m-RNA 合成服务的全球市场：按应用，2017-2030

• 治疗开发
• 疫苗製造
• 药物发现
• 其他

第 6 章 2017-2030 年全球 m-RNA 合成服务市场，按运营规模分列

• 研究
• 商业

第 7 章最终用户的 m-RNA 合成服务全球市场，2017-2030 年（百万美元

• 生物製药公司
• 合同研究组织 (CRO)
• 其他

第 8 章 2017-2030 年按地区分列的全球 m-RNA 合成服务市场

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• Maravai LifeSciences
• Azenta US, Inc.
• Creative Biolabs
• Becton, Dickinson And Company
• Creative Biogene
• Kaneka Corporation
• Danaher
• eTheRNA
• Biomay AG
• ApexBio Technology
• RiboPro
• F. Hoffmann-La Roche Ltd
• System Biosciences, LLC.
• Aurigene Pharmaceutical Services Ltd.
• OZ Biosciences
• Aldevron
• GenScript

第 10 章

• 调查方法
• 关于出版商

Messenger RNA (mRNA) synthesis, using DNA as the template, is called transcription. The mRNA carries the genetic information from the chromosomes' DNA in the nucleus to the surface of the cytosol. mRNA is a flexible tool that is utilized for gene editing, cell therapy, vaccinations, and therapeutic protein replacement, among other . The ability to introduce any protein via mRNA enables the cellular production of gene editing tools or antigens.

mRNA is a single-stranded RNA molecule that is complementary to one of a gene's DNA strands. Synthetic mRNAs are used to investigate protein-mediated mRNA recognition, mRNA export and translation, and mutation effects on protein-coding genes. Recently, mRNA-based medicines have been developed for the treatment of various diseases including respiratory, cardiac, metabolic and autoimmune diseases, as well as cancer, cancer immunotherapy, and preventive vaccinations.

Market Dynamics

Increasing number of acquisitions between market players is expected to drive the market growth over the forecast period. For instance, in January 2022, Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, announced that it has acquired MyChem, LLC, company focused on making ultra-pure nucleotides, for US$ 240 million. This acquisition will expand Maravai's product offering of strategic inputs in the rapidly growing markets for mRNA therapeutics and vaccine applications.

Increasing investments for m-RNA based technologies for m-RNA synthesis by the key players in the market in order to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in December 2021, Direxion, a financial corporation, announced the launch of the Direxion mRNA ETF, a new exchange-traded fund (ETF) that focuses on the applications and developments of messenger RNA technology. This fund seeks to invest in firms that are developing and applying mRNA technology.

Key features of the study:

• This report provides in-depth analysis of the global m-RNA synthesis service market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global m-RNA synthesis service market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include Maravai LifeSciences, Azenta US, Inc., Creative Biolabs, Becton, Dickinson And Company, Creative Biogene, Kaneka Corporation, Danaher, eTheRNA, Biomay AG, ApexBio Technology, RiboPro, F. Hoffmann-La Roche Ltd, System Biosciences, LLC., Aurigene Pharmaceutical Services Ltd., OZ Biosciences, Aldevron and GenScript
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global m-RNA synthesis service market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global m-RNA synthesis service market

Detailed Segmentation:

• Global m-RNA Synthesis Service Market, By Application:
  • Therapeutic Development
  • Vaccine Production
  • Drug Discovery
  • Others
• Global m-RNA Synthesis Service Market, By Scale of Operation:
  • Research
  • Commercial
• Global m-RNA Synthesis Service Market By End User:
  • Biopharmaceutical Companies
  • Contract research organizations (CROs)
  • Others
• Global m-RNA Synthesis Service Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Maravai LifeSciences*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Azenta US, Inc.
  • Creative Biolabs
  • Becton, Dickinson And Company
  • Creative Biogene
  • Kaneka Corporation
  • Danaher
  • eTheRNA
  • Biomay AG
  • ApexBio Technology
  • RiboPro
  • F. Hoffmann-La Roche Ltd
  • System Biosciences, LLC.
  • Aurigene Pharmaceutical Services Ltd.
  • OZ Biosciences
  • Aldevron
  • GenScript

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Application
  • Market Snapshot, By Scale of Operation
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Service Cost Analysis

4. Global m-RNA Synthesis Service Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global m-RNA Synthesis Service Market, By Application, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Therapeutic Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Vaccine Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global m-RNA Synthesis Service Market, By Scale of Operation, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017-2030
  • Segment Trends
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Commercial
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global m-RNA Synthesis Service Market, By End User, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global m-RNA Synthesis Service Market, By Region, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Scale of Operation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Maravai LifeSciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Azenta US, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton, Dickinson And Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Creative Biogene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Kaneka Corporation
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher
  • Company Highlights
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• eTheRNA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biomay AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ApexBio Technology
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• RiboPro
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• F. Hoffmann-La Roche Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• System Biosciences, LLC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aurigene Pharmaceutical Services Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OZ Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aldevron
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us